Enablex

This page contains recent news articles, when available, and an overview of Enablex but does not offer medical advice. You should contact your physician with regard to any health issues or concerns.

OTC, Personal Care Are Heating Up Again  -  ‎Dec 23, 2009‎
...dream of more than two decades to build a prescription-drug business when it divested a portfolio that included Actonel and Enablex to Warner Chilcott. ... AdAge.com (subscription)

'Go Ask Your Doctor if the Purple Pill is Right for You'  -  ‎Dec 10, 2009‎
Dorgan went on to do dramatic readings for sleep aids Ambien CR and Lunesta, and prostate drugs Enablex, and Flomax. The Flomax ad was really where he hit ... MedPage Today (blog)

Warner Chilcott: An Undervalued Growth Play  -  ‎Dec 21, 2009‎
However, investors are looking towards significant growth in Actonel, Asacol and Enablex, resulting from its acquisition of PGP on October 30, 2009. ... Sumfolio.com

P&G closes deal to sell drug arm  -  ‎Oct 30, 2009‎
...a treatment for ulcerative colitis; Actonel, an osteoporosis drug; and the co-promotion rights to Enablex for the treatment of overactive bladder. ... Cincinnati.com

Interstitial cystitis causes untold misery  -  ‎Nov 5, 2009‎
I take Elmiron, Prosed/DS and Enablex. Most people I know think of my problem as a bladder infection. They aren't familiar with IC. ... Inland Valley Daily Bulletin

Study demonstrates once-daily dose of Asacol(R) (mesalamine) is comparable to ...  -  ‎Oct 28, 2009‎
...of prescription products since the 1980s, including Actonel(R), Asacol(R), Enablex(R), Entex(R), Dantrium(R), Didronel(R), Macrobid(R), and Ziac(R). ... CNW Telbec (Communiqué de presse)

Warner Chilcott Q3 Profit Soars On Licensing Deal Gains - Update  -  ‎Nov 9, 2009‎
...ulcerative colitis drug Asacol HD, female sexual-dysfunction drug Intrinsa and the co-promotion rights to overactive bladder treatment drug Enablex. ... Trading Markets (press release)

Une étude prouve qu'une dose quotidienne unique d'Asacol(R) (mésalazine ...  -  ‎Oct 28, 2009‎
...délivrés sur ordonnance depuis les années 1980, dont Actonel(R), Asacol(R), Enablex(R), Entex(R), Dantrium(R), Didronel(R), Macrobid(R), and Ziac(R). ... Canada NewsWire (press release)

… and Procter & Gamble enter agreement for co-promotion of Enablex  -  Jul 6, 2005
Under the deal, Novartis will continue to record revenues for Enablex and will pay royalties to P&GP based on the product's performance, it said. ... Forbes

Beijing Med-Pharm, Shanghai Novartis to market Enablex in China  -  Nov 26, 2007
NEW YORK (Thomson Financial) - Beijing Med-Pharm Corp. and Novartis AG-subsidiary Shanghai Novartis Trading Ltd. Monday said they have agreed to jointly ... Forbes

Allergan predicts big growth for bladder drug  -  Feb 7, 2008
N) Ditropan XL, and Enablex, sold by Novartis (NOVN.VX) and Procter & Gamble Co. (PG.N). Allergan in January launched a new once-daily form of its bladder ... Reuters

Article: P&G MAKES DEAL TO MARKET DRUG.(Business) - The …  -  Jul 7, 2005
Enablex was approved for the treatment of overactive bladder with ... Abstract #5167) also indicate that Enablex reduces the number of weekly nocturnal ... ... Pay-Per-View - Cincinnati Post - HighBeam Research

New Data Show Overactive Bladder Therapy Enablex(R) Does Not Impair …  -  May 23, 2006
ATLANTA, May 23 /PRNewswire/ -- Data from a head-to-head clinical study looking at the effects of two prescription medications used to treat overactive ... Free with registration - PR Newswire - AccessMyLibrary.com

Notebook: Medicare In Nursing Homes  -  May 9, 2006
He wants her to take a drug called Enablex, which he says has the fewest ... His second phone call regards the Enablex issue and winds up taking 25 minutes. ... CBS News

OAB in Men: Anticholinergics and Antispasmodics -- Detrol, Enablex,...  -  Jul 21, 2008
These medicines calm the nerves that control bladder muscles. They may prevent uncontrollable bladder contractions that force urine out of the bladder. ... WebMD

FDA Approves Enablex for Treatment of Overactive Bladder  -  Sep 1, 2005
Novartis Pharmaceuticals Corporation today announced that the US Food and Drug Administration (FDA) has approved Enablex® (darifenacin) extended-release ... DentalPlans.com

… Medication for Incontinence -- Enablex, Detrol, Vesicare, and More  -  Sep 17, 2008
Anticholinergic medications block nerves that control bladder muscle contractions and allow for relaxation of the bladder smooth muscle. ... WebMD

Overactive Bladder Treatment Enablex(r) Does Not Impair Cognition in ...  -  Mar 1, 2005
A new study published in this month's Journal of Urology reports that Enablex® (darifenacin), a once-daily treatment for overactive bladder (OAB), ... i-newswire.com

Study Finds New Overactive Bladder Treatment Enablex(R) Does Not …  -  Feb 24, 2005
EAST HANOVER, NJ, Feb. 24 /PRNewswire/ -- A new study published in this month's Journal of Urology reports that Enablex(R) (darifenacin), a once-daily ... RedOrbit

P&G may sell pharmaceutical brands  -  Dec 11, 2008
The company's key pharmaceutical brands include Actonel – a $1 billion brand – Intrinsa, Enablex and Asacol. Lafley made his comments during P&G's biennial ... Bizjournals.com

… : New Data Show Overactive Bladder Therapy Enablex(R) Does Not …  -  May 23, 2006
New Data Show Overactive Bladder Therapy Enablex(R) Does Not Impair Memory Function Compared to Frequently Used Alternative. from PR Newswire. Pay-Per-View - PR Newswire - HighBeam Research

Overactive Bladder; US FDA approves Enablex for treatment of overactiv...  -  Jan 22, 2005
2005 JAN 22 - (NewsRx.com & NewsRx.net) -- Novartis Pharmaceuticals Corp. announced that the US Food and Drug Administration (FDA) has approved Enablex ... Pay-Per-View - Obesity, Fitness & Wellness Week - Factiva, from Dow Jones

… the airwaves for its overactive bladder drug Enablex.(NEWS)(Brief...  -  Mar 1, 2007
Novartis hit the airwaves for its overactive bladder drug Enablex.(NEWS)(Brief article) ... find Medical Marketing & Media articles. Pay-Per-View - Medical Marketing & Media - HighBeam Research

Bloomberg Printer-Friendly Page  -  May 6, 2008
Enablex(R) is a prescription medicine used in adults to treat symptoms of urinary ... Gao continued, "Enablex(R) is a great example of our ability to target ... Bloomberg

… ; Novartis says FDA approves anti-incontinence Enablex for US sales  -  Jan 10, 2005
..."Enablex isn't a very big drug for Novartis, but at least it was approved," ... Analysts expect Enablex to generate revenue of between US$350 million (EUR ... Pay-Per-View - Pharma Business Week - Factiva, from Dow Jones

Bladder Medication May Lead to Some Memory Loss  -  May 25, 2006
...s Enablex -- or a placebo daily. The dose was increased weekly over the three-week study. ... There was no change among those taking Enablex or placebo. ... Daily of the University of Washington - The Daily of the University of Washingto...

Novartis hit the airwaves for its overactive bladder drug Enablex.  -  Mar 1, 2007
Novartis hit the airwaves for its overactive bladder drug Enablex. [ILLUSTRATION OMITTED] Caption: NOVARTIS HIT THE AIRWAVES for its overactive bladder drug ... $9.94 - Medical Marketing & Media - Alacra Store

Overactive Bladder; US FDA approves Enablex for treatment of overactiv...  -  Jan 17, 2005
2005 JAN 17 - (NewsRx.com & NewsRx.net) -- Novartis Pharmaceuticals Corp. announced that the US Food and Drug Administration (FDA) has approved Enablex ... Pay-Per-View - Pharma Business Week - Factiva, from Dow Jones

ALSO NOTED: FDA blesses St. Jude heart valve; China Aoxing to sell …  -  Nov 26, 2007
Beijing Med-Pharm has inked a deal to market and distribute Enablex, a Novartis drug for overactive bladder, in China. Report ... FiercePharma

Is Your Bladder Out Of Control?  -  Mar 5, 2006
The most widely used are oxybutynin (marketed as Ditropan), tolterodine (Detrol LA), trospium (Sanctura), darifenacin (Enablex) and solifenacin (VESIcare). ... Parade Magazine

Novartis' Enablex cleared for OAB in USA.(overactive bladder)(Brief …  -  Jan 3, 2005
Swiss drugmaker Novartis has received approval for Enablex (darifenacin) 7.5mg and 15 mg extended-release tablets for the treatment of overactive bladder ... $4.95 - Pharma Marketletter - ECNext

… : BMP Sunstone Receives SFDA Acceptance for Enablex(R) Clinical...  -  May 6, 2008
BMP Sunstone Receives SFDA Acceptance for Enablex(R) Clinical Trial. from PR Newswire. Highbeam Research – FREE Trial. Pay-Per-View - PR Newswire - HighBeam Research

Incontinence drug does not seem to harm thinking  -  Mar 22, 2005
This study randomly assigned 129 people 65 years of age or older who did not have dementia to take darifenacin (Enablex) or a placebo daily. ... Spokesman-Review - The Spokesman Review

Overactive Bladder; US FDA approves Enablex for treatment of overactiv...  -  Jan 21, 2005
2005 JAN 21 - (NewsRx.com & NewsRx.net) -- Novartis Pharmaceuticals Corp. announced that the US Food and Drug Administration (FDA) has approved Enablex ... Pay-Per-View - Genomics & Genetics Weekly - Factiva, from Dow Jones

Enablex in elderly: no cognition impairment.(Novartis AG)(Brief...  -  Mar 7, 2005
Novartis' Enablex (darifenacin), a one-daily treatment for over-active bladder, does not impair cognition in elderly patients, according to a study ... Free with registration - Pharma Marketletter - AccessMyLibrary.com

Enablex.(News from the FDA)(Brief Article)  -  Feb 1, 2005
Enablex (darifenacin) was approved for the treatment of overactive bladder. It is available in 7.5-mg and 15-mg extended-release, once-daily oral tablets. ... Free with registration - Patient Care for the Nurse Practitioner - AccessMyLibrary.com

医è?¯é›†å›¢å’Œè¯ºå?Žç­¾ç½²Enablexå?ˆå?Œ  -  Nov 28, 2007
...北京医è?¯é›†å›¢å’Œä¸Šæµ·è¯ºå?ŽåŒ»è?¯è´¸æ˜“å…¬å?¸ï¼ˆç‘žå£«åˆ¶è?¯å…¬å?¸è¯ºå?Žçš„全资机构)签订了Enablex 销售å??议。å??议约定,诺å?ŽæŽˆäºˆåŒ—äº¬åŒ»è?¯é›†å›¢åœ¨å?Žç‹¬å®¶é”€å”®Enablexçš„æ?ƒåŠ›ã€‚ ... 中国网

… ; Novartis says FDA approves anti-incontinence Enablex for US sales  -  Jan 14, 2005
..."Enablex isn't a very big drug for Novartis, but at least it was approved," ... Analysts expect Enablex to generate revenue of between US$350 million (EUR ... Pay-Per-View - Drug Week - Factiva, from Dow Jones

… Gamble Enter into Commercialization Agreement for Enablex(R). - PR...  -  Jul 6, 2005
Novartis will continue to record revenues for Enablex and will pay royalties to ... Enablex is a potent muscarinic receptor antagonist that helps reduce ... Pay-Per-View - PR Newswire - HighBeam Research

Darifenacin (Enablex) increases the number of dry days in patients...  -  May 1, 2005
...* Darifenacin (Enablex) increases the number of dry days in patients with overactive bladder, according to results of a phase III trial. ... $4.95 - Urology Times - ECNext

Do Consumers Understand Drug Ads?  -  May 16, 2008
One ad that did a better job of helping viewers understand and remember risk information was for the bladder control drug Enablex, which features colorful ... TIME

Big opportunity seen for better bladder drugs  -  Jun 6, 2007
But Cleveland Clinic urologist Raymond Rackley said Enablex, sold by Novartis (NOVN. ... "Enablex has not proven to cause any cognitive problems," he said, ... Reuters

Arthur Frommer Tells America Where to Stop When They Need to Go  -  May 20, 2005
Enablex is indicated for the treatment of OAB with symptoms of urge urinary ... Enablex is a potent muscarinic receptor antagonist that helps reduce ... RedOrbit

Allergan expands bladder role with Esprit deal  -  Sep 19, 2007
N) Ditropan XL, and Enablex, sold by Novartis (NOVN.VX) and Procter & Gamble Co (PG.N). Allergan said it aims to launch Sanctura XR in the first quarter of ... Reuters

Overactive Bladder; Overactive bladder treatment does not impair …  -  Mar 25, 2005
Enablex has a unique M3 profile and is a potent muscarinic receptor antagonist that ... Enablex was approved by the US Food and Drug Administration (FDA) in ... Pay-Per-View - Drug Week - Factiva, from Dow Jones

When The Going Gets Tough…  -  Mar 12, 2007
...(PG ) recently kicked off a campaign for Enablex, a drug to treat overactive bladder. The TV ad features animated water balloons representing, well, ... BusinessWeek

Newer agents for the management of overactive bladder.(Clinical...  -  Dec 15, 2006
Enablex (darifenacin) [Prescribing information]. Stein, Switzerland: Novartis, 2005. 2. Ditropan (oxybutynin chloride) [Prescribing information]. ... $4.95 - American Family Physician - ECNext

Pipeline and Commercial Insight: Urinary Incontinence - Lifecycle …  -  Dec 26, 2007
At this point Detrol LA will be followed by the other second generation anticholinergics, GSK's Vesicare (solifenacin), Novartis' Enablex (darifenacin) and ... MarketResearch.com

Strong and steady: Novartis: most productive and strongest primary...  -  Mar 1, 2005
Enablex was approved by FDA in December for the treatment of overactive bladder. ... Novartis acquired Enablex in 2003 from Pfizer Inc. (pfizer.com). ... Pay-Per-View - Med Ad News - Factiva, from Dow Jones

Overactive Bladder Drugs Only Modestly Effective (press release)  -  Oct 25, 2006
In studies, Ditropan XL, Detrol LA, Oxytrol, Sanctura, Vesicare, and Enablex have caused fewer side effects. The report chose four Best Buys for people ... Natural News.com

AFX Europe Summary - late  -  Jul 6, 2005
Under the deal, Novartis will continue to record revenues for Enablex and will pay royalties to P&GP based on the product's performance, it said. ... Forbes

Pharma Blog Watch  -  Jul 14, 2008
...“Take for example the cute Enablex TV ads that depict people as colorful urine-filled ... Is THAT how Novartis and [Proctor & Gamble], marketers of Enablex, ... FDA news - FDA news (subscription)

Q1 2005 Indevus Pharmaceuticals, Inc. Earnings Conference Call - Part...  -  Feb 9, 2005
Yes, there has been Vesicare and Enablex samples entered into the market. ... We have not had any turnover due to Vesicare and Enablex since they have put ... Free with registration - America's Intelligence Wire - AccessMyLibrary.com

This is your TV on drugs  -  Aug 21, 2007
The two ads we see the most in this field - and we see them a lot - are Procter & Gamble's Enablex and Boehringer Ingelheim's Flomax. ... $3.50 - Press Telegram - NewsBank

Direct.  -  Oct 1, 2006
Enablex The "Where to Stop Where to Go" direct mail piece hits a bull's-eye. ... Enablex Client: Novartis Agency: MicroMass and Ketchum Pegasys ... $9.94 - Medical Marketing & Media - Alacra Store

Press Release: Healthier Cooking and Eating Becomes Easier Said and …  -  Apr 10, 2006
PR Newswire; March 26, 2008 ; 700+ words ... ... quality, leadership brands, including Actonel(R), Asacol(R), Enablex(R), Prilosec OTC(R), Metamucil(R), ... Pay-Per-View - PR Newswire - HighBeam Research

P&G keeps profit view despite softer sales  -  Dec 11, 2008
P&G's prescription drugs include Actonel and Enablex. Jon Moeller, who is set to become chief financial officer on January 1, said private label products ... Reuters

EU OKs Purchase of Chiron by Novartis | Article from AP Online | …  -  Feb 6, 2006
Novartis said Pfizer's Enablex ... Peapack, N.J. Part of the Novartis' payment to Pfizer, however ... Trade Commission and the European Commission must also ... Pay-Per-View - AP Online - HighBeam Research

INCONTINENCE DRUG DOES NOT BLOCK MENTAL ACUITY  -  Mar 29, 2005
This study randomly assigned 129 people 65 years of age or older who did not have dementia to take darifenacin (Enablex) or a placebo daily. ... $2.95 - St. Paul Pioneer Press - NewsBank

Store glasses will help you read tiny type, won't hurt the eyes ;...  -  Nov 25, 2005
You can also try drugs such as Tofranil, DDAVP or Ditropan, Detrol, Vesicare, Sanctura or Enablex. But bedwetting may recur if the drugs are stopped. ... Pay-Per-View - The Sun - ProQuest Archiver

Private view.  -  Apr 1, 2007
So while it may have been risky for Enablex to use a balloon as their graphic, they have succeeded in giving this icon new life. * Open chest ... $9.94 - Medical Marketing & Media - Alacra Store

Novartis restroom guide lands award.(Guide for tourists with overactiv...  -  Apr 1, 2006
ILLUSTRATION OMITTED] Caption: NOVARTIS HIT THE AIRWAVES for its overactive bladder drug Enablex. The colorful animated ads, executed by DDB New York, ... Pay-Per-View - Medical Marketing & Media - HighBeam Research

Rapp Collins Healthcare.(Update) | Article from Medical Marketing & …  -  Jun 1, 2007
Stephen Neale Copywriter: Jeff Chouinard 2007--Enablex Agency: DDB New York Client: ... NOVARTIS HIT THE AIRWAVES for its overactive bladder drug Enablex. ... Pay-Per-View - Medical Marketing & Media - HighBeam Research

Pelvic disorders common among US women -study  -  Sep 16, 2008
N); Vesicare or solifenacin made by GlaxoSmithKline (GSK.L) and Astellas Pharma Inc (4503.T); and Enablex or darifenacin by Novartis AG (NOVN.VX). ... Reuters

A Year in Review and Looking Ahead: New Pharmaceutical Treatment …  -  Dec 8, 2005
Darifenacin (Enablex) and soifenacin succinate (Vesicare) are new antimuscarinic agents for overactive bladder. [9,10] The side effect profile and efficacy ... Medscape

Hidden epidemic of pelvic floor problems  -  Aug 25, 2008
...to reduce nerve impulses that trigger bladder emptying: Ditropan, Detrol, Enablex, Sanctura and Vesicare. A common side effect with these is dry mouth. ... Los Angeles Times

Novartis Posts Higher Profit on Drug Sales | Article from AP Online |...  -  Apr 21, 2005
Novartis said Pfizer's Enablex ... N.J. Part of the Novartis' payment to Pfizer ... being obtained in the United States and European Union ... available ... Pay-Per-View - AP Online - HighBeam Research

Novartis Posts Profit on Prescription Drugs | Article from AP Online...  -  Apr 21, 2005
Novartis said Pfizer's Enablex ... N.J. Part of the Novartis' payment to Pfizer ... being obtained in the United States and European Union ... available ... Pay-Per-View - AP Online - HighBeam Research

Novartis Posts Profit on Strong Drug Sales | Article from AP Online |...  -  Apr 21, 2005
Novartis said Pfizer's Enablex ... N.J. Part of the Novartis' payment to Pfizer ... being obtained in the United States and European Union ... available ... Pay-Per-View - AP Online - HighBeam Research

Treatment for overactive bladder now available: Novartis.(New...  -  May 1, 2005
Novartis recently received FDA approval for darifenacin (Enablex), which is indicated for the treatment of overactive bladder. The drug marks the company's ... $4.95 - Urology Times - ECNext

Urinary Incontinence Medications - Urinary Incontinence Health …  -  Aug 12, 2008
In 2004, the FDA approved darifenacin (Enablex) for treatment of urge incontinence and overactive bladder. Some clinical trials suggested that darifenacin ... New York Times

Atlanta health, diet and fitness news | ajc.com  -  Sep 5, 2006
...a skin patch); tolterodine (Detrol, Detrol LA); trospium (Sanctura); solifenacin (Vesicare); and darifenacin (Enablex) -- can expect the number of times ... Atlanta Journal Constitution

Press Release: A Concise Analysis of the Most Important Information …  -  Jun 13, 2007
Article: New Data Show Overactive Bladder Therapy Enablex(R) ... PR Newswire; May 23, 2006 ; 700+ words ... ... Subjects receiving other overactive bladder ... Pay-Per-View - M2 Presswire - HighBeam Research

=> Novartis: Vertriebs-Allianz mit P&G <=  -  Jul 6, 2005
Novartis hat für sein Blasenmedikament "Enablex" für den US-Markt eine ... Enablex könnte dort künftig auch als rezeptfreies Medikament in Drogerien ... FinanzNachrichten.de

Overactive bladder  -  Sep 26, 2008
...trospium (Sanctura), solifenacin (Vesicare) and darifenacin (Enablex). These medications are usually used in combination with behavioral interventions. ... CNN International

Market Mover: Deirdre Kennedy  -  Jan 2, 2005
Recently, the US Food and Drug Administration approved its Enablex tablets which will be launched early this year. It is boosting production of its malaria ... Times Online

The Miami Herald South Florida, USA column: Writer lifts lid on loos.  -  Dec 18, 2006
...those among us who suffer from overactive bladders -- many of whom, it turns out, might possibly benefit from a Novartis drug called Enablex. ... Free with registration - Miami Herald - AccessMyLibrary.com

Warner Chilcott buying P&G drug unit for $3.1 billion  -  Jan 28, 2005
P&G's branded drugs, including osteoporosis treatment Actonel and Enablex for overactive bladder, have annual sales of $2.3 billion. ... IT Business Net - IT Business Net

Is it normal for adults to occasionally wet the bed?  -  Nov 21, 2005
You can also try drugs such as Tofranil, DDAVP or Ditropan, Detrol, Vesicare, Sanctura, or Enablex. But bed-wetting may recur if the drugs are stopped. Boston Globe

Article: Dr Miriam: Desperate for loo.(News) - The Mirror (London, …  -  Feb 23, 2005
Article: New Data Show Overactive Bladder Therapy Enablex(R) ... PR Newswire; May 23, 2006 ; 700+ words ... ... Subjects receiving other overactive bladder ... Pay-Per-View - The Mirror - HighBeam Research

Bladder troubles can lead to more serious problems; The latest …  -  Jan 24, 2005
...that work basically the same way with fewer side effects are Vesicare (solifenacin succinate), Sanctura (trospium chloride) and Enablex (darifenacin). ... Pay-Per-View - Los Angeles Times - ProQuest Archiver

Freedom from that gotta-go feeling  -  Aug 15, 2005
In just the past six months, Muller noted, the market has added three drugs that inhibit the troublemaking nerve impulses - Sanctura, VESIcare and Enablex ... Pay-Per-View - Philadelphia Inquirer - Factiva, from Dow Jones

BLADDER PROBLEMS ARE FAR-REACHING  -  Jan 11, 2005
...selective drugs that work basically the same way but with fewer side effects are Vesicare (solifenacin), Sanctura (trospium), and Enablex (darifenacin). ... $2.95 - Boston Globe - NewsBank

Treating Bladder Control Problems  -  Aug 15, 2005
Medications: Overactive bladder drugs include Enablex (Novartis Pharmaceuticals), Ditropan XL (Ortho-McNeil), Oxytrol (Watson Pharmaceuticals), ... Pay-Per-View - Philadelphia Inquirer - Factiva, from Dow Jones

Bladder problem can be more than just embarrassing  -  Jan 14, 2005
...drugs that work basically the same way, but with fewer side effects, are Vesicare (solifenacin), Sanctura (trospium) and Enablex (darifenacin). ... Pay-Per-View - The Sun - ProQuest Archiver

Treatment of Ulcerative Colitis With Asacol Improved Patient Quality...  -  Dec 1, 2006
The company has one of the strongest portfolios of trusted, quality, leadership brands, including Actonel, Asacol, Enablex, Prilosec OTC, Metamucil, ... Free with registration - PR Newswire - AccessMyLibrary.com

Celebrating UC Success Essay Contest Seeks Inspirational Stories of …  -  Dec 6, 2007
...has successfully developed and marketed a wide range of prescription products since the 1980s, including Actonel(R), Asacol(R), Enablex(R), Entex(R), ... Free with registration - PR Newswire - AccessMyLibrary.com

Can't leave home without it?  -  Nov 2, 2005
In just the past six months, Sanctura, VESIcare and Enablex have made their way into the market, a possible sign that incontinence is moving up on ... Times Herald-Record

KNIGHT RIDDER NEWSPAPERS  -  Aug 27, 2005
In just the past six months, Muller noted, the market has added three drugs that inhibit the troublemaking nerve impulses -- Sanctura, VESIcare and Enablex ... Youngstown Vindicator

Celebrating UC Success Announces Essay Contest Winners  -  May 12, 2008
...(etidronate disodium) tablets, Enablex(R) (darifenacin) extended release tablets and Macrobid(R) (nitrofurantoin monohydrate/macrocrystals) capsules. ... RedOrbit

Novartis Reports Strong Results in the First Six Months of 2005  -  Jul 14, 2005
...as productivity gains more than offset targeted investments to support Femara and Enablex in the US as well as to expand operations in China and Turkey. ... primezone.com

St. Louis Among the First to Offer Probiotic Supplement Align(R).  -  Nov 27, 2007
...leadership brands in consumer health and wellness, including Actonel(R), Align(R), Always(R), Asacol(R), Crest(R), Enablex(R), Metamucil(R), Oral-B(R), ... Free with registration - PR Newswire - AccessMyLibrary.com

BMP Sunstone Announces Pro Forma Financial Results for the Full Year ...  -  Apr 14, 2008
...notes that BMP Sunstone's reported 2007 financial results included approximately $2.0 million of costs related to licensing Enablex from Novartis. ... Genetic Engineering News - Genetic Engineering News (press release)

Side effects of anticholinergic drugs include:  -  Jun 26, 2006
In 2004, the FDA approved darifenacin (Enablex) for treatment of urge incontinence and overactive bladder. Some clinical trials suggested that darifenacin ... HealthCentral.com

GlobeNewswire, Inc. - News Room  -  Apr 21, 2005
Marketing & Sales expenses rose 14%, in particular for pre-launch and launch investments in products such as Enablex (incontinence), Femara (extended ... primezone.com

Statins and the Incidence of rhabdomyolysis.  -  Feb 1, 2005
Darifenacin, which is already available in Europe, will be marketed in the United States as Enablex. Drugs approved under the FDAs accelerated approval ... Pay-Per-View - Clinical Oncology Report - Factiva, from Dow Jones

New Study Suggests Number of Pills Not a Factor When it Comes to...  -  Jun 5, 2007
The company has one of the strongest portfolios of trusted, quality, leadership brands, including Actonel(R), Asacol(R), Enablex(R), Prilosec OTC(R), ... Free with registration - PR Newswire - AccessMyLibrary.com

Research and Markets : Urinary Incontinence who will control this...  -  Mar 29, 2005
New drug launches in OAB Vesicare (Yamanouchi) and Enablex (Novartis) could usurp Pfizer's dominance, while Yentreve will open up a new and underserved ... Free with registration - M2 Presswire - AccessMyLibrary.com

AgencyRx: CDM splinter is off to an explosive start, propelled by...  -  Jul 1, 2007
AgencyRx is AOR for all Novartis neuroscience brands and Enablex. It has significant oncology and pain management business, and retained all accounts last ... Free with registration - Medical Marketing & Media - AccessMyLibrary.com

New Study Suggests Number Of Pills Not A Factor When It Comes To …  -  Jun 6, 2007
The company has one of the strongest portfolios of trusted, quality, leadership brands, including Actonel(R), Asacol(R), Enablex(R), Prilosec OTC(R), ... Medical News Today - Medical News Today (press release)

Two New Analyses - Quality of Life and Medication Adherence, Offer …  -  May 22, 2007
The company has one of the strongest portfolios of trusted, quality, leadership brands, including Actonel(R), Asacol(R), Enablex(R), Prilosec OTC(R), ... Free with registration - PR Newswire - AccessMyLibrary.com

Pain in the "bladder neck"  -  Sep 29, 2007
My original urologist tried me on just about all OAB medications: Detrol, Ditropan, Enablex, etc. My current urologist is having me try Flomax, ... HealthCentral.com

NME approvals hit 5-year high in 2004.(new molecular entities )(Brief...  -  Feb 1, 2005
Novartis received one NME approval for its overactive bladder treatment Enablex. Merck and Johnson & Johnson failed to gain an NME approval. ... Free with registration - Medical Marketing & Media - AccessMyLibrary.com

Adult Male Bedwetting  -  Apr 7, 2008
He gave me a prescription for Enablex. Now I have switched from Flomax to over active bladder medication. I have also had back pain and had an MRI which ... HealthCentral.com

Urinary Incontinence Therapeutics Market Expected To Be Worth …  -  Jul 5, 2006
The market will expand with the introduction of new generation anticholinergics such as Astella Pharma's Vesicare and Enablex by Novartis. ... Genetic Engineering News - Genetic Engineering News (press release)

Elderly cognition, sleep unaffected by OAB drugs.  -  Apr 1, 2005
Darifenacin (Enablex) does not impair cognition in elderly patients being treated for overactive bladder, according to a study appearing in the Journal of ... Free with registration - Urology Times - AccessMyLibrary.com

Tolerability, safety vary among antimuscarinic agents: treatments for...  -  May 15, 2005
Darifenacin (Enablex), immediate-release oxybutynin, and propiverine (not available in the United States) were associated with a greater incidence of "any ... Free with registration - Urology Times - AccessMyLibrary.com

Ardana/Novartis commence marketing Emselex in UK.(contracts of …  -  Nov 27, 2006
Edinburgh, Scotland-based Ardana has commenced UK marketing of Emselex/Enablex (darifenacin), a novel M3-selective receptor antagonist for the once-daily ... Free with registration - Pharma Marketletter - AccessMyLibrary.com





Health Home | Conditions | Cancer | Medications | Surgery | Vaccines


The Cancer News Network


Disclaimer:

Contact a physician with regard to health concerns. Email requests for further health information will be discarded.

The materials contained on this Web site are for informational purposes only and do not constitute health or medical advice. Use of information on this site does not create or constitute any kind of agreement or contract between you and the owners or users of this site, the owners of the servers upon which it is housed, or anyone else who is in any way connected with this site.

Many links on cancernewsnetwork.org lead to other sites. cancernewsnetwork.org does not sponsor, endorse or otherwise approve of the materials appearing in such sites. Nor is CancerNewsNetwork.org responsible for dead or misdirected links.

IF YOU NEED A LINK OR TEXT REMOVED FROM THIS PAGE PLEASE CONTACT cancernewsnetwork (at) live.com.
We will do our best to accommodate your request.



COPYRIGHT 2009 CANCERNEWSNETWORK | Privacy